Biofrontera Inc. (BFRI) Q4 2025 Earnings Call Transcript

Operator

Welcome to the Biofrontera Inc. Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call. [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Ben Shamsian with Lytham Partners Investor Relations. Please go ahead.

Ben Shamsian

Thank you. Good morning, and welcome to Biofrontera’s Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call.

Please note that certain information discussed during today’s call by management is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrontera’s management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements due to the risks and uncertainties associated with the company’s business. All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera’s press releases and SEC filings, including the company’s annual report on Form 10-K and the year — for the year ended 12/31/2025.

Also, this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast. Biofrontera undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as required by law.

During today’s call, there will be references to certain non-GAAP financial measures. Biofrontera believes these measures provide useful information for investors, yet should not be considered as a substitute for GAAP nor should they